LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,353,685
تعداد دریافت فایل اصل مقاله7,275,279
Bolandi, Somayeh, Nakhaee, Maryam, Shirinzadeh, Laya, Jafarian, Amir Hossein, Davachi, Behrooz, Zavari, Tahereh, Shirzadeh, Fatemeh, Yousefi, Zohreh. (1400). Survival Rate of Non-Epithelial Ovarian Tumors in Iran. سامانه مدیریت نشریات علمی, 12(2), 302-309. doi: 10.30476/mejc.2020.82925.1124
Somayeh Bolandi; Maryam Nakhaee; Laya Shirinzadeh; Amir Hossein Jafarian; Behrooz Davachi; Tahereh Zavari; Fatemeh Shirzadeh; Zohreh Yousefi. "Survival Rate of Non-Epithelial Ovarian Tumors in Iran". سامانه مدیریت نشریات علمی, 12, 2, 1400, 302-309. doi: 10.30476/mejc.2020.82925.1124
Bolandi, Somayeh, Nakhaee, Maryam, Shirinzadeh, Laya, Jafarian, Amir Hossein, Davachi, Behrooz, Zavari, Tahereh, Shirzadeh, Fatemeh, Yousefi, Zohreh. (1400). 'Survival Rate of Non-Epithelial Ovarian Tumors in Iran', سامانه مدیریت نشریات علمی, 12(2), pp. 302-309. doi: 10.30476/mejc.2020.82925.1124
Bolandi, Somayeh, Nakhaee, Maryam, Shirinzadeh, Laya, Jafarian, Amir Hossein, Davachi, Behrooz, Zavari, Tahereh, Shirzadeh, Fatemeh, Yousefi, Zohreh. Survival Rate of Non-Epithelial Ovarian Tumors in Iran. سامانه مدیریت نشریات علمی, 1400; 12(2): 302-309. doi: 10.30476/mejc.2020.82925.1124

Survival Rate of Non-Epithelial Ovarian Tumors in Iran

Middle East Journal of Cancer
مقاله 17، دوره 12، شماره 2 - شماره پیاپی 46، تیر 2021، صفحه 302-309    اصل مقاله (907.98 K)
نوع مقاله: Middle East Special Report
شناسه دیجیتال (DOI): 10.30476/mejc.2020.82925.1124
نویسندگان
Somayeh Bolandi1؛ Maryam Nakhaee1؛ Laya Shirinzadeh1؛ Amir Hossein Jafarian2؛ Behrooz Davachi3؛ Tahereh Zavari1؛ Fatemeh Shirzadeh1؛ Zohreh Yousefi* 1
1Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Department of Radiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
Background: The aim of this study was to estimate the overall survival (OS) and relapse free survival (RFS) of the non-epithelial ovarian tumors (NEOTs) of ovarian germ cell tumors (OGCT) and ovarian sex cord tumors (OSCT) in Iranian women; we also evaluated the relative prognostic factors.
Method: In this retrospective study, we screened the documents of all the women diagnosed with OGCTs and OSCTs from 2012 to 2019. We further assessed the OS, RFS, and different prognostic factors.
Results: A statistically significant association existed between RFS and stage of the disease at diagnosis in OSCTs group by univariate analysis and multivariate analysis (HR: 0.25 (95% CI (0.08-0.78), P=0.01) and multivariate analysis (HR: 0.27 (95% CI (0.08-0.97), P=0.04), respectively. The kaplan-meier analysis and the Log Rrank (Mantel-Cox) showed a statistically significant relationship between the stage at diagnosis and RFS in OGCT group (P=0.042). RFS was 96% for OGCT patients, and 92.7% for OSCT patients. During the follow-up, only one patient passed away in the dysgerminoma group; the OS rate was 98% for OGCT patients, and 100% for OSCT patients.
Conclusion: The OS and RFS obtained in this study confirmed that the ovarian germ cell and sex cord malignancies were among the highly treatable solid tumors. Stage can be proposed as the main prognostic factor; also, larger series of studies are needed for detecting the prognostic significance of serum markers.
کلیدواژه‌ها
Survival؛ Ovarian cancer؛ Germ cell ovarian tumor؛ Sex cord ovarian tumor
اصل مقاله

How to cite this article:

Bolandi S, Nakhaee M, Shirinzadeh L, Jafarian A, Davachi B, Zavari T, et al. Survival rate of non-epithelial ovarian tumors in Iran. Middle East J Cancer. 2021;12(2): 302-9. doi: 10.30476/mejc.2020. 82925.1124.

آمار
تعداد مشاهده مقاله: 4,959
تعداد دریافت فایل اصل مقاله: 5,649


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب